Idorsia Swings to H1 Loss; Revenue Declines

MT Newswires · 2d ago
01:14 AM EDT, 07/30/2026 (MT Newswires) -- Idorsia (IDIA.SW) said Thursday that it swung to a net loss in the first half, while revenue declined year over year. Net loss for the six months ended June 30 was 153 million francs, compared with a profit of 52 million francs a year earlier. Loss per share was 0.60 franc, compared with an EPS of 0.26 franc. The Swiss biopharmaceutical group's net revenue was 110 million francs, compared with 131 million francs a year ago. Further, the company maintained its 2026 guidance. It still expects Quviviq product sales of 200 million francs and an operating loss of 160 million francs for the year.